{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:48:46Z","timestamp":1789076926775,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00834-6","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:53:23Z","timestamp":1761656003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genetic polymorphisms associated with metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk susceptibility in the Chinese Han population"],"prefix":"10.1186","volume":"19","author":[{"given":"Mingjia","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3","key":"834_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstrom H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u201352.","journal-title":"J Hepatol"},{"issue":"6","key":"834_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"5","key":"834_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"834_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","volume":"75","author":"P Golabi","year":"2021","unstructured":"Golabi P, Paik JM, Alqahtani S, Younossi Y, Tuncer G, Younossi ZM. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from Global burden of disease 2009\u20132019. J Hepatol. 2021;75(4):795\u2013809.","journal-title":"J Hepatol"},{"issue":"Suppl","key":"834_CR5","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"834_CR6","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"issue":"7","key":"834_CR7","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","volume":"149","author":"R Loomba","year":"2015","unstructured":"Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology. 2015;149(7):1784\u201393.","journal-title":"Gastroenterology"},{"issue":"2","key":"834_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol. 2018;68(2):268\u201379.","journal-title":"J Hepatol"},{"issue":"1","key":"834_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/apt.17292","volume":"57","author":"M Amangurbanova","year":"2023","unstructured":"Amangurbanova M, Huang DQ, Loomba R. Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD. Aliment Pharmacol Ther. 2023;57(1):37\u201351.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"834_CR10","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000400","volume":"12","author":"E Vilar-Gomez","year":"2021","unstructured":"Vilar-Gomez E, Pirola CJ, Sookoian S, Wilson LA, Liang T, Chalasani N. The protection conferred by HSD17B13 rs72613567 polymorphism on risk of steatohepatitis and fibrosis may be limited to selected subgroups of patients with NAFLD. Clin Transl Gastroenterol. 2021;12(9):e00400.","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"834_CR11","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.numecd.2021.02.018","volume":"31","author":"DQ Sun","year":"2021","unstructured":"Sun DQ, Wang TY, Zheng KI, Zhang HY, Wang XD, Targher G, et al. The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2021;31(6):1822\u201331.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"18","key":"834_CR12","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.18632\/aging.102293","volume":"11","author":"F Ji","year":"2019","unstructured":"Ji F, Liu Y, Hao JG, Wang LP, Dai MJ, Shen GF, et al. KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese. Aging (Albany NY). 2019;11(18):7847\u201358.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"834_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","volume":"73","author":"QM Anstee","year":"2020","unstructured":"Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, et al. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606). J Hepatol. 2020;73(3):505\u201315.","journal-title":"J Hepatol"},{"issue":"6","key":"834_CR14","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","volume":"72","author":"E Trepo","year":"2020","unstructured":"Trepo E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020;72(6):1196\u2013209.","journal-title":"J Hepatol"},{"issue":"6","key":"834_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","volume":"54","author":"M Vujkovic","year":"2022","unstructured":"Vujkovic M, Ramdas S, Lorenz KM, Guo X, Darlay R, Cordell HJ, et al. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. Nat Genet. 2022;54(6):761\u201371.","journal-title":"Nat Genet"},{"issue":"12","key":"834_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3417","volume":"47","author":"S Buch","year":"2015","unstructured":"Buch S, Stickel F, Trepo E, Way M, Herrmann A, Nischalke HD, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015;47(12):1443\u20138.","journal-title":"Nat Genet"},{"issue":"9403","key":"834_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363.","journal-title":"Lancet"},{"key":"834_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.","journal-title":"Gigascience"},{"issue":"2","key":"834_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.cr.7290272","volume":"15","author":"YY Shi","year":"2005","unstructured":"Shi YY, He L. Shesis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97\u20138.","journal-title":"Cell Res"},{"issue":"Web Server issu","key":"834_CR20","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web Server issue):W214\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"834_CR21","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790\u20137.","journal-title":"Genome Res"},{"issue":"Database issue","key":"834_CR22","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gkr917","volume":"40","author":"LD Ward","year":"2012","unstructured":"Ward LD, Kellis M. Haploreg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"834_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1101\/gr.104216.109","volume":"20","author":"A Lin","year":"2010","unstructured":"Lin A, Wang RT, Ahn S, Park CC, Smith DJ. A genome-wide map of human genetic interactions inferred from radiation hybrid genotypes. Genome Res. 2010;20(8):1122\u201332.","journal-title":"Genome Res"},{"issue":"2","key":"834_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2008.03.063","volume":"370","author":"Y Horiguchi","year":"2008","unstructured":"Horiguchi Y, Araki M, Motojima K. 17beta-hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein. Biochem Biophys Res Commun. 2008;370(2):235\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"834_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.481","volume":"5","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yu W, Li Y, Wang A, Cao H, Fu Y. Drug development advances in human genetics-based targets. MedComm (2020). 2024;5(2):e481.","journal-title":"MedComm (2020)"},{"key":"834_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108428","volume":"246","author":"MX Wang","year":"2023","unstructured":"Wang MX, Peng ZG. 17beta-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease. Pharmacol Ther. 2023;246:108428.","journal-title":"Pharmacol Ther"},{"key":"834_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/nu10010029","author":"A Saeed","year":"2017","unstructured":"Saeed A, Dullaart R, Schreuder T, Blokzijl H, Faber KN. Disturbed vitamin A metabolism in non-alcoholic fatty liver disease (NAFLD). Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu10010029.","journal-title":"Nutrients"},{"issue":"17","key":"834_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030739","volume":"12","author":"H Ihle-Hansen","year":"2023","unstructured":"Ihle-Hansen H, Vigen T, Berge T, Walle-Hansen MM, Hagberg G, Ihle-Hansen H, et al. Carotid plaque score for stroke and cardiovascular risk prediction in a middle-aged cohort from the general population. J Am Heart Assoc. 2023;12(17):e030739.","journal-title":"J Am Heart Assoc"},{"key":"834_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015473","author":"H Yanai","year":"2023","unstructured":"Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H. Metabolic-dysfunction-associated steatotic liver disease-its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242015473.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"834_CR30","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cpt.798","volume":"103","author":"DM Rotroff","year":"2018","unstructured":"Rotroff DM, Pijut SS, Marvel SW, Jack JR, Havener TM, Pujol A, et al. Genetic variants in HSD17B3, SMAD3, and IPO11 impact circulating lipids in response to fenofibrate in individuals with type 2 diabetes. Clin Pharmacol Ther. 2018;103(4):712\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"834_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.590669","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Wang X, Hu J, Du J, Dordoe C, et al. FGF20 protected against BBB disruption after traumatic brain injury by upregulating junction protein expression and inhibiting the inflammatory response. Front Pharmacol. 2020;11:590669.","journal-title":"Front Pharmacol"},{"issue":"6","key":"834_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10529-018-2554-z","volume":"40","author":"XG Xu","year":"2018","unstructured":"Xu XG, Gong L, Jiang TL, Li YH, Gao XH, Tian H, et al. Stimulation of mouse vibrissal follicle growth by recombinant human fibroblast growth factor 20. Biotechnol Lett. 2018;40(6):1009\u201314.","journal-title":"Biotechnol Lett"},{"issue":"5","key":"834_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.devcel.2018.07.010","volume":"46","author":"LM Yang","year":"2018","unstructured":"Yang LM, Huh SH, Ornitz DM. FGF20-expressing, Wnt-responsive olfactory epithelial progenitors regulate underlying turbinate growth to optimize surface area. Dev Cell. 2018;46(5):564-580.e5.","journal-title":"Dev Cell"},{"key":"834_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1150222","volume":"14","author":"AS Aaldijk","year":"2023","unstructured":"Aaldijk AS, Verzijl C, Jonker JW, Struik D. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho. Front Endocrinol (Lausanne). 2023;14:1150222.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"834_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101152","volume":"46","author":"S Talukdar","year":"2021","unstructured":"Talukdar S, Kharitonenkov A. FGF19 and FGF21. In NASH we trust. Mol Metab. 2021;46:101152.","journal-title":"Mol Metab"},{"key":"834_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103249","volume":"65","author":"N Panera","year":"2021","unstructured":"Panera N, Meroni M, Longo M, Crudele A, Valenti L, Bellacchio E, et al. The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation. EBioMedicine. 2021;65:103249.","journal-title":"EBioMedicine"},{"issue":"4","key":"834_CR37","first-page":"297","volume":"7","author":"H Gao","year":"2019","unstructured":"Gao H, Liu S, Zhao Z, Yu X, Liu Q, Xin Y, et al. Association of GCKR gene polymorphisms with the risk of nonalcoholic fatty liver disease and coronary artery disease in a Chinese northern Han population. J Clin Transl Hepatol. 2019;7(4):297\u2013303.","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"834_CR38","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.18632\/aging.203970","volume":"14","author":"F Yuan","year":"2022","unstructured":"Yuan F, Gu Z, Bi Y, Yuan R, Niu W, Ren D, et al. The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population. Aging (Albany NY). 2022;14(6):2736\u201347.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"834_CR39","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/hep.24806","volume":"55","author":"N Santoro","year":"2012","unstructured":"Santoro N, Zhang CK, Zhao H, Pakstis AJ, Kim G, Kursawe R, et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology. 2012;55(3):781\u20139.","journal-title":"Hepatology"},{"key":"834_CR40","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1038\/ncomms5309","volume":"5","author":"YL Liu","year":"2014","unstructured":"Liu YL, Reeves HL, Burt AD, Tiniakos D, Mcpherson S, Leathart JB, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:4309.","journal-title":"Nat Commun"},{"key":"834_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fgene.2016.00140","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Liu Z, Wang K, Wang Z, Sun X, Zhong L, et al. Additive effects of the risk alleles of PNPLA3 and TM6SF2 on non-alcoholic fatty liver disease (NAFLD) in a Chinese population. Front Genet. 2016;7:140.","journal-title":"Front Genet"},{"issue":"14","key":"834_CR42","first-page":"3106","volume":"25","author":"MJ Kim","year":"2016","unstructured":"Kim MJ, Yu CY, Theusch E, Naidoo D, Stevens K, Kuang YL, et al. SUGP1 is a novel regulator of cholesterol metabolism. Hum Mol Genet. 2016;25(14):3106\u201316.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"834_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng.2926","volume":"46","author":"OL Holmen","year":"2014","unstructured":"Holmen OL, Zhang H, Fan Y, Hovelson DH, Schmidt EM, Zhou W, et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat Genet. 2014;46(4):345\u201351.","journal-title":"Nat Genet"},{"issue":"4","key":"834_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybjaerg-Hansen A, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46(4):352\u20136.","journal-title":"Nat Genet"},{"issue":"2","key":"834_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204190","volume":"10","author":"Y He","year":"2023","unstructured":"He Y, B\u2019nai Taub A, Yu L, Yao Y, Zhang R, Zahr T, et al. PPAR\u03b3 acetylation orchestrates adipose plasticity and metabolic rhythms. Adv Sci (Weinh). 2023;10(2):e2204190.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"834_CR46","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1096\/fj.10-173716","volume":"25","author":"E Mor\u00e1n-Salvador","year":"2011","unstructured":"Mor\u00e1n-Salvador E, L\u00f3pez-Parra M, Garc\u00eda-Alonso V, Titos E, Mart\u00ednez-Clemente M, Gonz\u00e1lez-P\u00e9riz A, et al. Role for PPAR\u03b3 in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB J. 2011;25(8):2538\u201350.","journal-title":"FASEB J"},{"key":"834_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020243","author":"P Ustianowski","year":"2022","unstructured":"Ustianowski P, Malinowski D, Safranow K, Dziedziejko V, Tarnowski M, Pawlik A. PPARG, TMEM163, UBE2E2, and WFS1 gene polymorphisms are not significant risk factors for gestational diabetes in the Polish population. J Pers Med. 2022. https:\/\/doi.org\/10.3390\/jpm12020243.","journal-title":"J Pers Med"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00834-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:05:25Z","timestamp":1761696325000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00834-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00834-6","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethic Committee of the Affiliated Hospital of Xuzhou Medical University (XYFY2024-KL571-01). Since this study mainly uses discarded blood samples from the hospital, the ethics committee was exempt from informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}